ASAN FOUNDATION
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI)
Recruiting
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2023-04-11
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 3000
- Registration Number
- NCT05807841
- Locations
- 🇰🇷
Soon Chun Hyang University Hospital Bucheon, Bucheon, Korea, Republic of
🇰🇷Gosin University Gospel Hospital, Busan, Korea, Republic of
🇰🇷Inje University Pusan Paik Hospital, Busan, Korea, Republic of
IntravasCular Imaging-Guided Versus AngiogRaphy-GUided Drug-Eluting Stent Implantation for Fermoropopliteal Artery Disease
Not Applicable
Recruiting
- Conditions
- Femoropopliteal Disease
- Interventions
- Device: intravascular ultrasound-guided groupDevice: angiography-guided group
- First Posted Date
- 2023-04-07
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT05805280
- Locations
- 🇰🇷
Veterans Hospital, Daegu, Korea, Republic of
🇰🇷Inje University Busan Paik Hospital, Busan, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
A Study to Evaluate Coronary Atherosclerosis in Patients With Diabetes Mellitus
Recruiting
- Conditions
- Diabetes Mellitus
- First Posted Date
- 2023-04-06
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 511
- Registration Number
- NCT05801432
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
Phase 4
Completed
- Conditions
- Atherosclerosis of ArteryCoronary Artery DiseasePeripheral Arterial DiseaseCarotid Stenosis
- Interventions
- First Posted Date
- 2023-04-04
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 92
- Registration Number
- NCT05797376
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Standardization of Anti-Seizure Medications Withdrawals After Seizure Remission in Young Patients With Epilepsy
Recruiting
- Conditions
- EpilepsyEpilepsy in Children
- First Posted Date
- 2023-02-23
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 1200
- Registration Number
- NCT05740423
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Mobile Application for Cardiovascular Risk Treatment
Not Applicable
Not yet recruiting
- Conditions
- Lifestyle Risk ReductionHypertensionHyperlipidemiasChronic Disease
- Interventions
- Behavioral: App-guided lifestyle modificationBehavioral: A book-based self-education of lifestyle modification
- First Posted Date
- 2023-02-03
- Last Posted Date
- 2023-02-03
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 450
- Registration Number
- NCT05712070
Feasibility and Accuracy of Core Temperature Measurements Using the Esophageal Temperature Probe Inserted Through the Gastric Lumen of Supraglottic Airway Device in Pediatrics
Completed
- Conditions
- Supraglottic Airway DevicePediatric ALLTemperature Change, Body
- First Posted Date
- 2023-01-30
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 42
- Registration Number
- NCT05705206
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Comparison of Recovery Profiles Among Propofol, Remimazolam, and Dexmedetomidine After Intraoperative Sedation
Phase 4
Completed
- Conditions
- Brachial Plexus BlockPropofolDexmedetomidineRemimazolamOrthopedic ProceduresSedatives
- Interventions
- First Posted Date
- 2023-01-18
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 120
- Registration Number
- NCT05688345
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Patient Blood Mangement (PBM) Using IV Iron in Patients With Gynecologic Cancer
Not Applicable
Not yet recruiting
- Conditions
- Gynecologic Cancer
- Interventions
- Drug: RBCDrug: Ferric Carboxymaltose 50Mg/Ml Inj 20Ml
- First Posted Date
- 2023-01-03
- Last Posted Date
- 2023-01-05
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 334
- Registration Number
- NCT05669872
- Locations
- 🇰🇷
Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of
The Efficacy and Safety of Temozolomide in SDH-deficient GIST
- First Posted Date
- 2022-12-22
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 29
- Registration Number
- NCT05661643
- Locations
- 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath